Home » Topics » BioWorld

BioWorld
RSS

ONCOGENE COMPLETES ACQUISITION

Oct. 8, 1991

REPLIGEN GETS PATENT RIGHTS FOR ANTIBODIES

Oct. 8, 1991

MID-ATLANTIC VENTURE FAIR

Oct. 7, 1991

APPOINTMENTS AND ADVANCEMENTS

Oct. 7, 1991

BTG'S BIOTROPIN ENTERS PHASE I TRIALS

Oct. 7, 1991

GENZYME PLACES $100M IN NOTES

Oct. 7, 1991

CARRINGTON TRADES ON AMERICAN EXCHANGE

Oct. 7, 1991

AGOURON FILES FOR 2 MILLION-SHARE OFFERING

Oct. 7, 1991

POTENTIAL 'BLOCKBUSTER' FOR LTIZ

Oct. 7, 1991

ICOS TO CO-DEVELOP DRUGS WITH GLAXO

Oct. 7, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...